Agomab Therapeutics AGMB Cash Flow Statement (2024-2025)

NASDAQ AGMB

$13.43 -0.32 (-2.33%)

At close: Aug 20, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2024	Dec2025
Operating Activities
Share-based Compensation (Quarter)	9.11M	16.15M

Agomab Therapeutics (AGMB)

NASDAQ: AGMB

$13.43 ▼ -0.32 (-2.33%)

Aug 20, 2026 · 4:00 PM EDT